Fetal Aneuploidy Detection by Maternal Plasma DNA Sequencing

Judith Walsh, MD, MPH

Disclosures

CTAF 

In This Article

Recommendation

The following recommendation was proposed:

It is recommended that the use of cell free fetal DNA as a prenatal screening test for fetal aneuploidy for Trisomy 21, Trisomy 18, and Trisomy 13 does not meet CTAF criteria 4 and 5 for safety and efficacy and improvement in health outcomes.

The CTAF panel voted three in favor of the recommendation as written and six opposed. No alternative recommendation was proposed and so CTAF did not endorse any final recommendation regarding this technology.

June 20, 2012

This is the first review of this technology by CTAF.

Comments

3090D553-9492-4563-8681-AD288FA52ACE

processing....